Europe Small Molecule API Market Outlook, 2029

The Europe Small Molecule API Market is expected to reach a staggering USD 105.2 billion by 2030, driven by rise in R&D investments.

According to publisher, Europe's small molecule Active Pharmaceutical Ingredient (API) market is a vital cog in the pharmaceutical industry, supplying the essential building blocks for a vast array of medications. Market Insights

What's Inside a Bonafide Research`s industry report?

Asia-Pacific dominates the market and is the largest and fastest-growing market in the animal growth promoters industry globally

Download Sample

Market Size and Growth: The European small molecule API market is expected to reach a staggering USD 105.2 billion by 2030, boasting a healthy CAGR exceeding 8%. This growth signifies the continued reliance on small molecules for drug development and production in Europe. Growth Drivers: Several factors are propelling the European small molecule API market forward: Aging Population: Europe's aging population creates a rising demand for medications, particularly those targeting chronic diseases treatable with small molecule APIs.

Make this report your own

Have queries/questions regarding a report?

Take advantage of intelligence tailored to your business objective

Manmayi Raval

Manmayi Raval

Research Consultant

Increasing R&D Investments: Pharmaceutical companies in Europe are investing heavily in research and development (R&D) of new drugs, often utilizing small molecules for their well-defined properties and ease of manufacturing. Example: A leading pharmaceutical company in Switzerland might invest in R&D for a novel small molecule treatment for Alzheimer's disease, addressing a growing healthcare need within the aging European population. Focus on Cost-Effectiveness: Healthcare systems across Europe emphasize cost-effectiveness. Small molecule APIs often offer a more affordable production option compared to biologics, making them a preferred choice for many medications. Market Dynamics

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now
Manmayi Raval

The European small molecule API market is a dynamic environment influenced by several key forces: Regulatory Landscape: Stringent regulations from the European Medicines Agency (EMA) ensure the safety and efficacy of APIs used in medications. This necessitates robust quality control measures within the manufacturing process. Supply Chain Complexity: The European small molecule API market has a complex global supply chain, with ingredients sourced from various regions. This can create challenges in terms of ensuring quality and managing disruptions. Environmental Sustainability: Growing environmental concerns are pushing manufacturers to adopt eco-friendly practices throughout the API production process. Market Segments The European small molecule API market can be segmented based on various criteria: Therapeutic Area: Cardiovascular drugs Oncology drugs Central nervous system (CNS) drugs Respiratory drugs And others API Type: Generic APIs Branded APIs Regional Analysis The European small molecule API market exhibits variations across different regions: Western Europe: Western Europe is a dominant region, with established pharmaceutical companies and a well-developed manufacturing infrastructure. Countries like Germany, France, and Switzerland are major players. Central and Eastern Europe (CEE): The CEE region is experiencing growth in the small molecule API market, driven by lower production costs and government initiatives to attract investments in the pharmaceutical sector. Poland, Hungary, and Romania are emerging players. Key Developments Contract Manufacturing: Contract manufacturing organizations (CMOs) are playing an increasingly important role, offering European pharmaceutical companies flexibility and scalability in API production. Focus on Continuous Improvement: Leading manufacturers are continuously improving production processes to enhance efficiency, reduce costs, and minimize environmental impact. Competitive Landscape The European small molecule API market is a competitive landscape with a mix of established pharmaceutical companies, specialty API manufacturers, and contract manufacturing organizations (CMOs): Big Pharma: Major pharmaceutical companies often have their own in-house API production facilities alongside partnerships with CMOs for specific needs. Specialty API Manufacturers: These companies focus on the production of specific types of APIs, often catering to niche markets or complex molecules. Contract Manufacturing Organizations (CMOs): CMOs offer a wide range of API manufacturing services to pharmaceutical companies, providing flexibility and expertise in the production process. By understanding these key aspects, stakeholders within the European small molecule API market can navigate the evolving landscape and capitalize on the vast opportunities it presents.

Table of Contents

  • 1 Introduction 8
  • 1.1 Industry Definition and Research Scope 8
  • 1.1.1 Industry Definition 8
  • 1.1.2 Research Scope 9
  • 1.2 Research Methodology 12
  • 1.2.1 Overview of Market Research Methodology 12
  • 1.2.2 Market Assumption 13
  • 1.2.3 Secondary Data 13
  • 1.2.4 Primary Data 13
  • 1.2.5 Data Filtration and Model Design 14
  • 1.2.6 Market Size/Share Estimation 15
  • 1.2.7 Research Limitations 16
  • 1.3 Executive Summary 17
  • 2 Market Overview and Dynamics 20
  • 2.1 Market Size and Forecast 20
  • 2.1.1 Impact of COVID-19 on World Economy 21
  • 2.1.2 Impact of COVID-19 on the Market 24
  • 2.1.3 Impact of Russia-Ukraine Conflict: War Slows Economic Recovery 26
  • 2.2 Major Growth Drivers 30
  • 2.3 Market Restraints and Challenges 34
  • 2.4 Emerging Opportunities and Market Trends 37
  • 2.5 Porter’s Fiver Forces Analysis 41
  • 3 Segmentation of Europe Market by Source 45
  • 3.1 Market Overview by Source 45
  • 3.2 Synthetic API 47
  • 3.2.1 Branded Synthetic API 48
  • 3.2.2 Generic Synthetic API 49
  • 3.3 Semi-synthetic API 50
  • 3.4 Natural Origin 51
  • 4 Segmentation of Europe Market by Product Type 52
  • 4.1 Market Overview by Product Type 52
  • 4.2 Standard API 54
  • 4.3 High Potency API (HPAPI) 55
  • 4.3.1 Branded HPAPI 56
  • 4.3.2 Generic HPAPI 57
  • 5 Segmentation of Europe Market by Therapeutic Area 58
  • 5.1 Market Overview by Therapeutic Area 58
  • 5.2 Infectious Diseases 60
  • 5.3 Oncology 61
  • 5.4 Ophthalmology 62
  • 5.5 Cardiovascular Disorders 63
  • 5.6 Central Nervous System 64
  • 5.7 Respiratory Disorders 65
  • 5.8 Metabolic Diseases 66
  • 5.9 Other Therapeutic Areas 67
  • 6 Segmentation of Europe Market by Application 68
  • 6.1 Market Overview by Application 68
  • 6.2 Clinical Use 70
  • 6.3 Commercial Use 71
  • 7 Segmentation of Europe Market by Manufacturer Type 72
  • 7.1 Market Overview by Manufacturer Type 72
  • 7.2 Pharmaceutical Companies 74
  • 7.3 CMOs 76
  • 8 European Market 2022-2032 by Country 78
  • 8.1 Overview of European Market 78
  • 8.2 Germany 81
  • 8.3 U.K. 83
  • 8.4 France 85
  • 8.5 Spain 87
  • 8.6 Italy 89
  • 8.7 Russia 91
  • 8.8 Rest of European Market 93
  • 9 Competitive Landscape 95
  • 9.1 Overview of Key Vendors 95
  • 9.2 New Product Launch, Partnership, Investment, and M&A 98
  • 9.3 Company Profiles 99
  • Aurobindo Pharma Ltd. 99
  • Cambrex Corporation 101
  • Catalent Inc. 102
  • Dr. Reddy's Laboratories 105
  • GlaxoSmithKline plc 108
  • Lonza Group 112
  • Merck & Co., Inc. 115
  • Mylan N.V. 117
  • Novartis AG 119
  • Pfizer Inc. 121
  • Sun Pharmaceutical Industries Ltd. 125
  • Teva Pharmaceutical Industries Ltd. 128
  • Wuxi AppTec Co., Ltd. 130
  • RELATED REPORTS 132



Table 1. Snapshot of Europe Small Molecule API Market in Balanced Perspective, 2022-2032 18
Table 2. World Economic Outlook, 2021-2031 22
Table 3. World Economic Outlook, 2021-2023 23
Table 4. Scenarios for Economic Impact of Ukraine Crisis 27
Table 5. World Health Spending by Region, $ bn, 2013-2020 32
Table 6. World Top 10 Pharmaceutical Companies Based on Projected R&D Spending in 2026, $ bn 33
Table 7. Main Product Trends and Market Opportunities in Europe Small Molecule API Market 37
Table 8. Europe Small Molecule API Market by Source, 2022-2032, $ mn 45
Table 9. Europe Small Molecule API Market: Synthetic API by Drug Type, 2022-2032, $ mn 47
Table 10. Europe Small Molecule API Market by Product Type, 2022-2032, $ mn 52
Table 11. Europe Small Molecule API Market: HPAPI by Drug Type, 2022-2032, $ mn 55
Table 12. Europe Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 58
Table 13. Europe Small Molecule API Market by Application, 2022-2032, $ mn 68
Table 14. Europe Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 72
Table 15. Europe Small Molecule API Market by Country, 2022-2032, $ mn 80
Table 16. Germany Small Molecule API Market by Product Type, 2022-2032, $ mn 82
Table 17. Germany Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 82
Table 18. Germany Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 82
Table 19. U.K. Small Molecule API Market by Product Type, 2022-2032, $ mn 84
Table 20. U.K. Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 84
Table 21. U.K. Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 84
Table 22. France Small Molecule API Market by Product Type, 2022-2032, $ mn 86
Table 23. France Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 86
Table 24. France Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 86
Table 25. Spain Small Molecule API Market by Product Type, 2022-2032, $ mn 88
Table 26. Spain Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 88
Table 27. Spain Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 88
Table 28. Italy Small Molecule API Market by Product Type, 2022-2032, $ mn 90
Table 29. Italy Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 90
Table 30. Italy Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 90
Table 31. Russia Small Molecule API Market by Product Type, 2022-2032, $ mn 92
Table 32. Russia Small Molecule API Market by Therapeutic Area, 2022-2032, $ mn 92
Table 33. Russia Small Molecule API Market by Manufacturer Type, 2022-2032, $ mn 92
Table 34. Small Molecule API Market in Rest of Europe by Country, 2022-2032, $ mn 94
Table 35. Aurobindo Pharma Ltd.: Company Snapshot 99
Table 36. Aurobindo Pharma Ltd.: Business Segmentation 100
Table 37. Aurobindo Pharma Ltd.: Product Portfolio 100
Table 38. Cambrex Corporation: Company Snapshot 101
Table 39. Catalent Inc.: Company Snapshot 102
Table 40. Catalent Inc.: Business Segmentation in 2018 102
Table 41. Catalent Inc.: Product Portfolio 103
Table 42. Catalent Inc.: Revenue, 2018-2020, $ million 103
Table 43. Catalent Inc.: Revenue by Region in 2018 104
Table 44. Dr. Reddy's Laboratories: Company Snapshot 105
Table 45. Dr. Reddy's Laboratories: Business Segmentation 105
Table 46. Dr. Reddy's Laboratories: Revenue, 2018-2020, $ bn 106
Table 47. GlaxoSmithKline: Company Snapshot 108
Table 48. GlaxoSmithKline: Business Segmentation 109
Table 49. GlaxoSmithKline: Product Portfolio 110
Table 50. GlaxoSmithKline: Revenue, 2018-2020, $ bn 111
Table 51. Lonza Group: Company Snapshot 112
Table 52. Lonza Group: Business Segmentation in 2018 112
Table 53. Lonza Group: Product Portfolio 113
Table 54. Lonza Group: Revenue by Region in 2018 113
Table 55. Merck & Co., Inc.: Company Snapshot 115
Table 56. Merck & Co., Inc.: Business Segmentation 115
Table 57. Merck & Co., Inc.: Revenue, 2018-2020, $ bn 116
Table 58. Mylan NV: Company Snapshot 117
Table 59. Mylan NV: Revenue, 2017-2019, $ bn 118
Table 60. Novartis International AG: Company Snapshot 119
Table 61. Novartis International AG: Business Segmentation 119
Table 62. Novartis International AG: Revenue, 2017-2019, $ bn 120
Table 63. Pfizer Inc.: Company Snapshot 121
Table 64. Pfizer Inc.: Business Segmentation 122
Table 65. Pfizer Inc.: Product Portfolio 123
Table 66. Pfizer Inc.: Revenue, 2018-2020, $ bn 123
Table 67. Sun Pharmaceutical Industries Limited: Company Snapshot 125
Table 68. Teva Pharmaceutical Industries Ltd.: Company Snapshot 128
Table 69. Teva Pharmaceutical Industries Ltd.: Business Segmentation 129
Table 70. WuXi AppTec Inc.: Company Snapshot 130



Figure 1. Research Method Flow Chart 12
Figure 2. Bottom-up Approach and Top-down Approach for Market Estimation 15
Figure 3. Europe Market Forecast in Optimistic, Conservative and Balanced Perspectives, 2022-2032 17
Figure 4. Europe Small Molecule API Market, 2022-2032, $ mn 20
Figure 5. Impact of COVID-19 on Business 24
Figure 6. Primary Drivers and Impact Factors of Europe Small Molecule API Market 30
Figure 7. Primary Restraints and Impact Factors of Europe Small Molecule API Market 34
Figure 8. Investment Opportunity Analysis 38
Figure 9. Porter’s Fiver Forces Analysis of Europe Small Molecule API Market 41
Figure 10. Breakdown of Europe Small Molecule API Market by Source, 2022-2032, % of Revenue 46
Figure 11. Europe Addressable Market Cap in 2023-2032 by Source, Value ($ mn) and Share (%) 46
Figure 12. Europe Small Molecule API Market by Source: Synthetic API, 2022-2032, $ mn 47
Figure 13. Europe Small Molecule API Market by Synthetic API: Branded Synthetic API, 2022-2032, $ mn 48
Figure 14. Europe Small Molecule API Market by Synthetic API: Generic Synthetic API, 2022-2032, $ mn 49
Figure 15. Europe Small Molecule API Market by Source: Semi-synthetic API, 2022-2032, $ mn 50
Figure 16. Europe Small Molecule API Market by Source: Natural Origin, 2022-2032, $ mn 51
Figure 17. Breakdown of Europe Small Molecule API Market by Product Type, 2022-2032, % of Sales Revenue 53
Figure 18. Europe Addressable Market Cap in 2023-2032 by Product Type, Value ($ mn) and Share (%) 53
Figure 19. Europe Small Molecule API Market by Product Type: Standard API, 2022-2032, $ mn 54
Figure 20. Europe Small Molecule API Market by Product Type: High Potency API (HPAPI), 2022-2032, $ mn 55
Figure 21. Europe Small Molecule API Market by HPAPI: Branded HPAPI, 2022-2032, $ mn 56
Figure 22. Europe Small Molecule API Market by HPAPI: Generic HPAPI, 2022-2032, $ mn 57
Figure 23. Breakdown of Europe Small Molecule API Market by Therapeutic Area, 2022-2032, % of Sales Revenue 59
Figure 24. Europe Addressable Market Cap in 2023-2032 by Therapeutic Area, Value ($ mn) and Share (%) 59
Figure 25. Europe Small Molecule API Market by Therapeutic Area: Infectious Diseases, 2022-2032, $ mn 60
Figure 26. Europe Small Molecule API Market by Therapeutic Area: Oncology, 2022-2032, $ mn 61
Figure 27. Europe Small Molecule API Market by Therapeutic Area: Ophthalmology, 2022-2032, $ mn 62
Figure 28. Europe Small Molecule API Market by Therapeutic Area: Cardiovascular Disorders, 2022-2032, $ mn 63
Figure 29. Europe Small Molecule API Market by Therapeutic Area: Central Nervous System, 2022-2032, $ mn 64
Figure 30. Europe Small Molecule API Market by Therapeutic Area: Respiratory Disorders, 2022-2032, $ mn 65
Figure 31. Europe Small Molecule API Market by Therapeutic Area: Metabolic Diseases, 2022-2032, $ mn 66
Figure 32. Europe Small Molecule API Market by Therapeutic Area: Other Therapeutic Areas, 2022-2032, $ mn 67
Figure 33. Breakdown of Europe Small Molecule API Market by Application, 2022-2032, % of Revenue 69
Figure 34. Europe Addressable Market Cap in 2023-2032 by Application, Value ($ mn) and Share (%) 69
Figure 35. Europe Small Molecule API Market by Application: Clinical Use, 2022-2032, $ mn 70
Figure 36. Europe Small Molecule API Market by Application: Commercial Use, 2022-2032, $ mn 71
Figure 37. Breakdown of Europe Small Molecule API Market by Manufacturer Type, 2022-2032, % of Revenue 73
Figure 38. Europe Addressable Market Cap in 2023-2032 by Manufacturer Type, Value ($ mn) and Share (%) 73
Figure 39. Europe Small Molecule API Market by Manufacturer Type: Pharmaceutical Companies, 2022-2032, $ mn 74
Figure 40. Breakdown of Europe Small Molecule API In-house Synthesis Market by Region, 2020-2027, % of Revenue 75
Figure 41. Europe Small Molecule API Market by Manufacturer Type: CMOs, 2022-2032, $ mn 76
Figure 42. Breakdown of Europe Small Molecule API Contract Synthesis Market by Region, 2020-2027, % of Revenue 77
Figure 43. Breakdown of European Small Molecule API Market by Country, 2022 and 2032, % of Revenue 79
Figure 44. Contribution to Europe 2023-2032 Cumulative Market by Country, Value ($ mn) and Share (%) 80
Figure 45. Small Molecule API Market in Germany, 2022-2032, $ mn 81
Figure 46. Small Molecule API Market in U.K., 2022-2032, $ mn 83
Figure 47. Small Molecule API Market in France, 2022-2032, $ mn 85
Figure 48. Small Molecule API Market in Spain, 2022-2032, $ mn 87
Figure 49. Small Molecule API Market in Italy, 2022-2032, $ mn 89
Figure 50. Small Molecule API Market in Russia, 2022-2032, $ mn 91
Figure 51. Small Molecule API Market in Rest of Europe, 2022-2032, $ mn 93
Figure 52. Growth Stage of Europe Small Molecule API Industry over the Forecast Period 95
Logo

Europe Small Molecule API Market Outlook, 2029

Contact usWe are friendly and approachable, give us a call.